| Status: Medicine does not meet criteria for AWMSG assessment | |
Excluded from appraisal by AWMSG as meets exclusion criteria 5. See AWMSG criteria for appraising a medicine (PDF, 430Kb) for information. |
|
Medicine details |
|
| Medicine name | calcipotriol / betamethasone (Wynzora®) |
| Formulation | 50 micrograms/g + 0.5 mg/g cream |
| Reference number | 4786 |
| Indication | Topical treatment of mild to moderate psoriasis vulgaris, including scalp psoriasis, in adults |
| Company | Almirall Ltd |
| BNF chapter | Skin |
| Submission type | N/A |
| Status | Medicine does not meet criteria for AWMSG assessment |
| Date of issue | 03/09/2021 |